From the blog

An International Study on Pediatric Patients With Rare Tumors. (PARTNER)

Published: July 25, 2025

Primary Outcome Measures

  • Epidemiology
  • Use of International Recommendations
  • Survival of children and adolescents (0-18 years) affected by Very Rare Tumors

Inclusion Criteria

  • Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
  • Written informed consent from the patient and/or the parent/legal guardian

Exclusion Criteria

  • Absence of Written informed consent from the patient and/or the parent/legal guardian
Contact Us
CONTACT INFORMATION
DIAGNOSIS
Have you received a diagnosis? *
reCAPTCHA

Quick Facts

Added:
July 25, 2025

Last Updated:
July 25, 2025

Accepts Healthy Volunteers:
No

Ages Eligible for Study:
0 Years to 18 Years (Child, Adult )

ClinicalTrials.gov Identifier:
NCT07072143

Contact:
Name: Gianni Bisogno, MD
Phone Number: 0039 0498211481
Email: gianni.bisogno@unipd.it

Estimated Enrollment:
6,250

Estimated Primary Completion Date:
2049-01-06

Estimated Study Start Date:
2025-01-25

Genders Eligible for Study:
All

Status:
Recruiting